These results indicate that Ibudilast may be a well-tolerated and safe modulator of neuroinflammation in glaucoma, and that PDE4 represents a potential target for research into inhibiting chronic gliosis and neuroinflammation in glaucoma (Rolle et al., 2021). The gene discussed is PDE4A; the disease is glaucoma.